With the exception of a few countries, Asia’s disease management industry is relatively unstructured.
While Western countries still have more medical device startups than the rest of the world, more new medtech startups are popping up in Asia than ever before.
As standalone software becomes increasingly sophisticated, a number of regulatory bodies have begun to draft separate guidelines to ensure quality control, expedite product approval, and improve patient access to new technologies.
Growth of the Asian cloud computing market is expected to accelerate as healthcare providers streamline their operations in today’s paperless world.
Foreign device companies can expect a big opportunity for expansion in Southeast Asia.
The booming industry is creating new opportunities for medtech manufacturers.
As the incidence of diabetes across Asia expands, demand for medical devices and drugs to treat the disease is intensifying.
Contributing factors include a change in lifestyle, an increase in wealth, and chronic infections in rural regions.